244 related articles for article (PubMed ID: 36466914)
1. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
3. Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
Nakamura N; Goto N; Tsurumi H; Takemura M; Kanemura N; Kasahara S; Hara T; Yasuda I; Shimizu M; Sawada M; Yamada T; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2013 Oct; 91(4):322-31. PubMed ID: 23672298
[TBL] [Abstract][Full Text] [Related]
4. Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell Leukemia.
Kato M; Imaizumi N; Tanaka R; Mizuguchi M; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Todoroki J; Karube K; Masuzaki H; Tanaka Y; Fukushima T
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458481
[TBL] [Abstract][Full Text] [Related]
5. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
[TBL] [Abstract][Full Text] [Related]
6. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
[TBL] [Abstract][Full Text] [Related]
8. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.
Purdue MP; Hofmann JN; Kemp TJ; Chaturvedi AK; Lan Q; Park JH; Pfeiffer RM; Hildesheim A; Pinto LA; Rothman N
Blood; 2013 Aug; 122(6):951-7. PubMed ID: 23814017
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.
Guerrero CLH; Yamashita Y; Miyara M; Imaizumi N; Kato M; Sakihama S; Hayashi M; Miyagi T; Karimata K; Uchihara J; Ohshiro K; Todoroki J; Nakachi S; Morishima S; Karube K; Tanaka Y; Masuzaki H; Fukushima T
Blood Adv; 2020 Mar; 4(6):1062-1071. PubMed ID: 32196559
[TBL] [Abstract][Full Text] [Related]
11. An alternative spliced variant of circulating soluble tumor necrosis factor-alpha receptor-2 is paradoxically associated with insulin action.
Fernández-Real JM; Straczkowski M; Lainez B; Chacón MR; Kowalska I; López-Bermejo A; García-España A; Nikolajuk A; Kinalska I; Ricart W
Eur J Endocrinol; 2006 May; 154(5):723-30. PubMed ID: 16645020
[TBL] [Abstract][Full Text] [Related]
12. Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis.
Yang N; Huang J; Frits M; Iannaccone C; Weinblatt ME; Rifai N; Shadick N; Bradwin G; Liao KP
Pract Lab Med; 2019 Aug; 16():e00122. PubMed ID: 31193412
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis.
Arjmand MH; Moradi A; Akbari A; Mehrad-Majd H
Cytokine; 2020 Jan; 125():154869. PubMed ID: 31585311
[TBL] [Abstract][Full Text] [Related]
16. Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort.
Marrone MT; Lu J; Visvanathan K; Joshu CE; Platz EA
Cancer Causes Control; 2021 Aug; 32(8):871-881. PubMed ID: 33999316
[TBL] [Abstract][Full Text] [Related]
17. Levels of soluble tumor necrosis factor receptor 1 and 2 are associated with survival after ST segment elevation myocardial infarction.
Befekadu R; Grenegård M; Larsson A; Christensen K; Ramström S
Sci Rep; 2022 Aug; 12(1):14762. PubMed ID: 36042366
[TBL] [Abstract][Full Text] [Related]
18. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
[TBL] [Abstract][Full Text] [Related]
19. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
Front Immunol; 2017; 8():1482. PubMed ID: 29163543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
